Diarrhea Global Clinical Trials Review, H2, 2017
July 2017
414
About the Report
About the Report
Diarrhea Global Clinical Trials Review, H2, 2017
Summary
GlobalData's clinical trial report, "Diarrhea Global Clinical Trials Review, H2, 2017" provides an overview of Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Diarrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Products
Products
Diarrhea Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Diarrhea, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania
Companies
GlaxoSmithKline Plc
Merck & Co Inc
International Centre for Diarrhoeal Disease Research Bangladesh
Sanofi
Novartis AG
Johnson & Johnson
Ipsen SA
Astellas Pharma Inc
Valeant Pharmaceuticals International Inc
Nestle SA
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Diarrhea to Gastrointestinal Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Diarrhea to Gastrointestinal Clinical Trials 21
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Diarrhea Therapeutics Clinical Trials 34
Prominent Drugs 36
Latest Clinical Trials News on Diarrhea 37
Jul 17, 2017: RedHill Biopharma Announces Last Patient Visit in BEKINDA Phase II Study for IBS-D 37
Jul 10, 2017: Allergan Reports New Data Reinforcing the Effectiveness of Viberzi to Treat the Symptoms Associated with Irritable Bowel Syndrome with Diarrhea, Abdominal Pain and Diarrhea 37
May 01, 2017: Allergan to Present New and Updated Viberzi at Digestive Disease Week 2017 38
Clinical Trial Profile Snapshots 39
Appendix 412
Abbreviations 412
Definitions 412
Research Methodology 413
Secondary Research 413
About GlobalData 414
Contact Us 414
Source 414
List of Figure
List of Figures
Diarrhea Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Diarrhea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Diarrhea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Diarrhea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
Diarrhea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
Diarrhea Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
Diarrhea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 15
Diarrhea Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 16
Proportion of Diarrhea to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 17
Diarrhea Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Diarrhea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Diarrhea to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 21
Diarrhea Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
Diarrhea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
Diarrhea Therapeutics, Global, Clinical Trials by Phase (%), 2017* 25
Diarrhea Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 26
Diarrhea Therapeutics, Global, Clinical Trials by Trial Status, 2017* 27
Diarrhea Therapeutics Clinical Trials, Global, by End Point Status, 2017* 29
Diarrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 30
Diarrhea Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 31
Diarrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 32
Diarrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 34
Diarrhea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 36
GlobalData Methodology 413
List of Table
List of Tables
Diarrhea Therapeutics, Global, Clinical Trials by Region, 2017* 8
Diarrhea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10
Diarrhea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Diarrhea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
Diarrhea Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
Diarrhea Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
Diarrhea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 15
Diarrhea Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 16
Proportion of Diarrhea to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 17
Diarrhea Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Diarrhea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
Proportion of Diarrhea to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 21
Diarrhea Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
Diarrhea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
Diarrhea Therapeutics, Global, Clinical Trials by Phase, 2017* 25
Diarrhea Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 26
Diarrhea Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28
Diarrhea Therapeutics Clinical Trials, Global, by End Point Status, 2017* 29
Diarrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 30
Diarrhea Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 31
Diarrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33
Diarrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35
Diarrhea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 36
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.